(internal quotation marks and citation omitted). The court first turned to indirect purchaser plaintiffs’ injunctive relief claim under Section 16 the Clayton Act, 15 U.S.C. § 26. The court noted that plaintiffs sought to enjoin not just any future reverse payment agreements related to Plavix, but went "so far as to request to enjoin Defendants from the possibility of entering into a yet-to-be-determined reverse payment agreement on some yet unidentified drug."